MCA-V30P is mainly used for patients with mild to moderate respiratory failure, no indication of emergency intubation, relatively stable vital signs and no taboo of noninvasive ventilation. It is used for early intervention and auxiliary evacuation of respiratory failure.
Nowadays,COVID-19 which causedby the novel coronavirus outbreaks worldwide.The virus will quickly invadehuman lung cells and cause pneumonia, which will cause severe lower respiratory tract diseases, such as acute lung injurya- nd respiratory distress syndrome. Some critical pati-entmay even have symptoms such as respiratory failure, refractory hypoxemia,shock,mul-t iple organ failure,and coagulopathy.
For COVID-19,ventilator is one of the most effective treatments in the absence of specific drugs.Under ventilated, the blood oxygen of patientcan be effectively improved and the mortality rate can be reduced.
Using environments 1. Early intervention for respiratory failure for patients with COVID-19; 2. After extubating, when the patient is removed from the invasive ventilator and transferred to a non-invasive ventilator.The patient has a certain ability to breathe spontaneously and is in good condition, or applied when transferred to a general ward.
Guidelines for non-invasive ventilation for patients with COVID-19 For mild to moderate patients (PaO2<60mmHg,SpO2<90%,RR>24), non-invasive ventilation can be considered for respiratory support when oxygen therapy is not effective.
Qualification: ISO 13485, CE0197, ISO14001, ISO 9001